Daily as of 3 Nov 16:00 ET
- Price
- below both $49.99 vs 50 $53.86 / 200 $52.84
- Projection
- 💀Death cross projected in 10 bars
- Test
- No active test
- Last cross
- 🟨Golden cross 23 Sep 2026 · projected 9 bars out · tested 6 bars
CRSP | CRISPR Therapeutics AGNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$49.99
$0.00 (0.00%)
CRISPR Therapeutics AG (CRSP) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2017.
Right now the daily is the chart to watch. The 50 SMA has sat above the 200 since Sep 2026, but the two have been closing on each other and a death cross is projected within 10 bars. Price sits below the 50 and the 200 on the daily, the weekly and the 4-hour.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- below both $51.42 vs 50 $52.88 / 200 $53.01
- Projection
- 🟨Golden cross estimated 15+ weeks out
- Test
- Cross test window open, no test bar yet
- Last cross
- 💀Death cross week of 19 Oct 2026 · projected 22 bars out
4-hour as of 3 Nov 13:30 ET
- Price
- below both $50.66 vs 50 $51.98 / 200 $53.39
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 23 Oct 2026 · projected 16 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 23 Oct 2026 | 💀Death | 4-hour | 16 bars out | Not tested |
| week of 19 Oct 2026 | 💀Death flat | weekly | 22 bars out | Active Cross Test |
| 23 Sep 2026 | 🟨Golden flat | daily | 9 bars out | 6 bar cross test |
| 15 Sep 2026 | 💀Death flat | daily | 7 bars out | 2 bar cross test |
| 27 Aug 2026 | 🟨Golden | 4-hour | 25 bars out | Not tested |
About CRSP
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$69.2M
4-hour coverageYes, since Oct 2025
History on recordSince 2017
SectorHealthcare
Cap bandmid